資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/31593
|
| 標題: | AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78 |
| 作者: | Chen, Hsin-Hsin
Chen, Chien-Chin
Lin, Yee-Shin
Chang, Po-Chun
Lu, Zi-Yi
Lin, Chiou-Feng
Chen, Chia-Ling
Chang, Chih-Peng |
| 貢獻者: | Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol
Chia Yi Christian Hosp, Dept Pathol
Chia Nan Univ Pharm & Sci, Dept Cosmet Sci
Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med
Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res
Taipei Med Univ, Grad Inst Med Sci, Coll Med
Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med
Taipei Med Univ, Translat Res Ctr |
| 關鍵字: | AR-12
Dengue
PI3K/AKT
GRP78
Antivirus |
| 日期: | 2017-06 |
| 上傳時間: | 2018-11-30 15:49:30 (UTC+8) |
| 出版者: | Elsevier Science Bv |
| 摘要: | Dengue virus (DENV) infection has become a public health issue of worldwide concern and is a serious health problem in Taiwan, yet there are no approved effective antiviral drugs to treat DENV. The replication of DENV requires both viral and cellular factors. Targeting host factors may provide a potential antiviral strategy. It has been known that up-regulation of PI3K/AKT signaling and GRP78 by DENV infection supports its replication. AR-12, a celecoxib derivative with no inhibiting activity on cyclooxygenase, shows potent inhibitory activities on both PI3K/AKT signaling and GRP78 expression levels, and recently has been found to block the replication of several hemorrhagic fever viruses. However the efficacy of AR-12 in treating DENV infection is still unclear. Here, we provide evidence to show that AR-12 is able to suppress DENV replication before or after virus infection in cell culture and mice. The antiviral activities of AR-12 are positive against infection of the four different DENV serotypes. AR-12 significantly down-regulates the PI3K/AKT activity and GRP78 expression in DENV infected cells whereas AKT and GRP78 rescue are able to attenuate anti-DENV effect of AR-12. Using a DENV-infected suckling mice model, we further demonstrate that treatment of AR-12 before or after DENV infection reduces virus replication and mice mortality. In conclusion, we uncover the potential efficacy of AR-12 as a novel drug for treating dengue. (C) 2017 Elsevier B.V. All rights reserved. |
| 關聯: | Antiviral Research, v.142, pp.158-168 |
| 顯示於類別: | [化妝品應用與管理系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 1457 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
